Article

Clinicopathologic Features among Pathogenic Variants/Likely Pathogenic Variants, Variants of Unknown Significance, and Wild Type of BRCA1/2 in Breast Cancer

2022-05-05

Abstract excerpt

<h4>Background: </h4> Approximately 5–10% of breast cancers are BRCA-positive. Because of higher grades and proliferation indices, these prognoses are poor compared to sporadic breast cancers. This study analyzed the clinicopathologic features of breast cancer based on BRCA gene status. Methods A total of 315 women with breast cancer underwent genetic assessments between 2006 and 2019. BRCA gene status was classi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5bcc38b3-36d6-52b8-9f0a-87a1af0394c9
DOI: 10.21203/rs.3.rs-1613800/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinicopathologic Features among Pathogenic Variants/Likely Pathogenic Variants, Variants of Unknown Significance, and Wild Type of BRCA1/2 in Breast CancerDOI 10.21203/rs.3.rs-1613800/v1Read

Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer.Semantic proximity Read

Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study.Semantic proximity Read

Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer.Semantic proximity Read

Cancer Incidence Rates Between BRCA1/2 Pathogenic Variant Carriers and Non-Carriers in Real-World Clinical Practice.Semantic proximity Read

Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.Semantic proximity Read

Analysis of BRCA1/2 variants of unknown significance in patients with breast cancer from a prospective KOHBRA studySemantic proximity Read

BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies.Semantic proximity Read

Assessing germline mutational profile and its clinicopathological associations in Triple Negative Breast CancerSemantic proximity Read

BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning.Semantic proximity Read

Genetic, Surgical and Oncological Approach to Breast Cancer, with BRCA1, BRCA2, CDH1, PALB2, PTEN and TP53 VariantsSemantic proximity Read

Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis.Semantic proximity Read

Incidence of contralateral and ipsilateral breast cancers and prognosis in BRCA1/2 pathogenic variant carriers based on the Japanese HBOC Consortium registration.Semantic proximity Read